News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
London Marathon runners raise thousands for the ICR
A team of runners is on target to raise more than £55,000 for the ICR at this year’s London Marathon on the 35th anniversary of the world-famous race.
Genetic ‘signature’ points to poor blood cancer outcome
Testing for a DNA signature could predict which patients with myeloma – a cancer of immune cells in the blood and bone marrow – are likely to develop more serious disease, with a reduced chance of survival.
ICR PhD student wins Women in Cancer Research Award
PhD Student Dr Charlotte Pawlyn has won an award for her research presented at the prestigious international American Association of Cancer Research conference in Philadelphia.
Trial shows benefit of ‘BRCA-targeting’ drug in prostate cancer
Men with prostate cancer benefited from treatment with the pioneering drug olaparib – a drug which targets BRCA gene mutations.
Over drinks, three ICR researchers talk science
Join ICR scientists at the Somers Town Coffee House and learn about their research.
Using the seeds of cancer to guide treatment strategies
Circulating tumour cells can act as ‘seeds’ – breaking away from the primary tumour and colonising other sites in the body. But they are also becoming an increasingly useful tool in cancer medicine – measuring a patient’s state of disease.
Genetic screening could improve breast cancer prevention
A test for a wide range of genetic risk factors could improve doctors’ ability to work out which women are at increased risk of developing breast cancer, a major study of more than 65,000 women has shown.
Scientists drill down to genetic root of prostate tumour development
Research from an international collaboration of scientists has revealed new clues to the genetic causes of prostate cancer that has spread to other parts of the body.
Consortium signs deal with Basilea to develop resistance-busting cancer drugs
The cross-institution agreement with Basilea Pharmaceutica Ltd. will progress a new family of cancer drugs designed to tackle drug-resistant cancers.
Professor Paul Workman to co-host ‘Horizons in Cancer Drug Discovery’
Professor Paul Workman, Chief Executive of The Institute of Cancer Research, London, is to co-host ‘Horizons in Cancer Drug Discovery’ – a meeting of minds of academia, the pharmaceutical industry and investors to discuss innovative methods of cancer drug discovery.
New role uncovered for ‘oldest’ tumour suppressor gene
A new function has been found for one of the first cancer genes ever discovered.
Using multiple imaging measures could improve prostate cancer diagnosis
Combining a variety of different imaging parameters could be more accurate at diagnosing prostate cancer than an experienced radiologist.
